Orchidia Pharmaceutical Industries
PrivateLast Round
Buyout/LBO
Mar 11, 2026
Est. Valuation
$85.5M
Total Funding Raised
$39.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Orchidia Pharmaceutical Industries operates in Healthcare & Life Sciences and is based in Cairo. Its latest recorded funding round was a Private Equity round in November 2017.
Orchidia Pharmaceutical Industries is a pharmaceutical company that manufactures and develops ophthalmic medications, nutritional supplements, and cosmetic products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orchidia Pharmaceutical Industries Comparables
Compare Orchidia Pharmaceutical Industries with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EVA Pharma | 78% | |
| Laboratoires Théa | 78% | |
| URSAPHARM Arzneimittel GmbH | 78% |
For institutional investors. Book with your work email.
Orchidia Pharmaceutical Industries Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Buyout/LBO | Mar 11, 2026 | ||||
| Private Equity | Nov 7, 2017 | ||||
| Private Equity | Jan 1, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Orchidia Pharmaceutical Industries Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Proparco | Buyout/LBO |
| EAEF | Private Equity |
| European Bank for Reconstruction and Development | Buyout/LBO |
| SPE Capital | Private Equity, Buyout/LBO |
| Lorax Capital Partners | Private Equity |
| Belgian Investment Company for Developing Countries | Buyout/LBO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2026
SPE Capital led the round with participation from Proparco, Belgian Investment Company, and EBRD.
- May 2, 2025
Monthly visitors increased 93% MoM, reaching 19.9K.
For institutional investors. Book with your work email.
Orchidia Pharmaceutical Industries Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Orchidia Pharmaceutical Industries's valuation, stock price, and market status.
Is Orchidia Pharmaceutical Industries a public or private company?
Orchidia Pharmaceutical Industries is a private company.
What is the current stock price of Orchidia Pharmaceutical Industries?
Orchidia Pharmaceutical Industries is a private company, so its shares have no public market price. Caplight tracks Orchidia Pharmaceutical Industries's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Orchidia Pharmaceutical Industries worth (valuation)?
Orchidia Pharmaceutical Industries's valuation is estimated at $85.5M based on funding round data.
Can I buy Orchidia Pharmaceutical Industries stock?
Orchidia Pharmaceutical Industries shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Orchidia Pharmaceutical Industries's last funding round?
Orchidia Pharmaceutical Industries's most recent funding round was Buyout/LBO on March 11, 2026.
Who are the main investors in Orchidia Pharmaceutical Industries?
Key investors in Orchidia Pharmaceutical Industries include EAEF, SPE Capital.
Will Orchidia Pharmaceutical Industries IPO soon?
No public IPO plans have been announced for Orchidia Pharmaceutical Industries.
How can I track Orchidia Pharmaceutical Industries secondary market activity?
Caplight tracks bids, offers, and trades in Orchidia Pharmaceutical Industries's shares on secondary markets.